Browse Studies — Arctuva

Phase 2

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

Background: * Membranous nephropathy is associated with damage to the walls of the glomeruli, the small blood vessels in the kidneys that filter waste product…

Nephrotic SyndromeProteinuriaAutoimmune Disease+2 more

Estimated

~$10 – $5,625

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00977977

Phase 3

A Multicenter Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Zigakibart in Adults With Primary IgA Nephropathy.

The purpose of this study is to determine if zigakibart is safe and effective for long-term use in patients with immunoglobulin A nephropathy (IgAN). This is a…

Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more

Estimated

~$10 – $8,750

Novartis PharmaceuticalsNCT06858319

The Impact of Glomerular Disorders on Bone Quality and Strength

The primary objectives of this study are to: (1) determine the impact of glomerular disease on bone strength and (2) investigate the pathophysiologic underpinn…

Glomerular DiseaseBone Diseases, MetabolicBone Fracture

Estimated

~$10 – $750

Columbia UniversityNCT04528446

Preparing a Clinical Outcomes Assessment Set for Nephrotic Syndrome

Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interview…

Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more

Estimated

~$10 – $750

University of MichiganNCT05505500